BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 38062286)

  • 21. Macrophages and pancreatic ductal adenocarcinoma.
    Habtezion A; Edderkaoui M; Pandol SJ
    Cancer Lett; 2016 Oct; 381(1):211-6. PubMed ID: 26708507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FAK inhibition radiosensitizes pancreatic ductal adenocarcinoma cells in vitro.
    Mohamed AA; Thomsen A; Follo M; Zamboglou C; Bronsert P; Mostafa H; Amen A; Mekawy M; Grosu AL; Brunner TB
    Strahlenther Onkol; 2021 Jan; 197(1):27-38. PubMed ID: 32705304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression and role of the immune checkpoint regulator PD-L1 in the tumor-stroma interplay of pancreatic ductal adenocarcinoma.
    Daunke T; Beckinger S; Rahn S; Krüger S; Heckl S; Schäfer H; Wesch D; Pilarsky C; Eckstein M; Hartmann A; Röcken C; Wandmacher AM; Sebens S
    Front Immunol; 2023; 14():1157397. PubMed ID: 37449210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumour cell-derived debris and IgG synergistically promote metastasis of pancreatic cancer by inducing inflammation via tumour-associated macrophages.
    Chen Q; Wang J; Zhang Q; Zhang J; Lou Y; Yang J; Chen Y; Wei T; Zhang J; Fu Q; Ye M; Zhang X; Dang X; Liang T; Bai X
    Br J Cancer; 2019 Oct; 121(9):786-795. PubMed ID: 31588122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alteration of tumor-associated macrophage subtypes mediated by KRT6A in pancreatic ductal adenocarcinoma.
    Zhang J; Sun H; Liu S; Huang W; Gu J; Zhao Z; Qin H; Luo L; Yang J; Fang Y; Ge J; Ni B; Wang H
    Aging (Albany NY); 2020 Nov; 12(22):23217-23232. PubMed ID: 33221741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune Checkpoint Inhibition for Pancreatic Ductal Adenocarcinoma: Current Limitations and Future Options.
    Kabacaoglu D; Ciecielski KJ; Ruess DA; Algül H
    Front Immunol; 2018; 9():1878. PubMed ID: 30158932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Developing a 3D B Cell Lymphoma Culture System to Model Antibody Therapy.
    Foxall R; Narang P; Glaysher B; Hub E; Teal E; Coles MC; Ashton-Key M; Beers SA; Cragg MS
    Front Immunol; 2020; 11():605231. PubMed ID: 33628205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity.
    Hezaveh K; Shinde RS; Klötgen A; Halaby MJ; Lamorte S; Ciudad MT; Quevedo R; Neufeld L; Liu ZQ; Jin R; Grünwald BT; Foerster EG; Chaharlangi D; Guo M; Makhijani P; Zhang X; Pugh TJ; Pinto DM; Co IL; McGuigan AP; Jang GH; Khokha R; Ohashi PS; O'Kane GM; Gallinger S; Navarre WW; Maughan H; Philpott DJ; Brooks DG; McGaha TL
    Immunity; 2022 Feb; 55(2):324-340.e8. PubMed ID: 35139353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Homogeneous pancreatic cancer spheroids mimic growth pattern of circulating tumor cell clusters and macrometastases: displaying heterogeneity and crater-like structure on inner layer.
    Feng H; Ou BC; Zhao JK; Yin S; Lu AG; Oechsle E; Thasler WE
    J Cancer Res Clin Oncol; 2017 Sep; 143(9):1771-1786. PubMed ID: 28497169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune cell distribution and DNA methylation signatures differ between tumor and stroma enriched compartment in pancreatic ductal adenocarcinoma.
    Tomasich E; Mühlbacher J; Wöran K; Hatziioannou T; Herac M; Kleinberger M; Berger JM; Dibon LK; Berchtold L; Heller G; Bergen ES; Macher-Beer A; Prager G; Schindl M; Preusser M; Berghoff AS
    Transl Res; 2024 Sep; 271():40-51. PubMed ID: 38734064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting both tumour-associated CXCR2
    Nywening TM; Belt BA; Cullinan DR; Panni RZ; Han BJ; Sanford DE; Jacobs RC; Ye J; Patel AA; Gillanders WE; Fields RC; DeNardo DG; Hawkins WG; Goedegebuure P; Linehan DC
    Gut; 2018 Jun; 67(6):1112-1123. PubMed ID: 29196437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TIMP-2 secreted by monocyte-like cells is a potent suppressor of invadopodia formation in pancreatic cancer cells.
    Benzing C; Lam H; Tsang CM; Rimmer A; Arroyo-Berdugo Y; Calle Y; Wells CM
    BMC Cancer; 2019 Dec; 19(1):1214. PubMed ID: 31836008
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stratified 3D Microtumors as Organotypic Testing Platforms for Screening Pancreatic Cancer Therapies.
    Monteiro MV; Gaspar VM; Mendes L; Duarte IF; Mano JF
    Small Methods; 2021 May; 5(5):e2001207. PubMed ID: 34928079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Establishment and Analysis of a 3D Co-Culture Spheroid Model of Pancreatic Adenocarcinoma for Application in Drug Discovery.
    Meier-Hubberten JC; Sanderson MP
    Methods Mol Biol; 2019; 1953():163-179. PubMed ID: 30912022
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emodin reduces Breast Cancer Lung Metastasis by suppressing Macrophage-induced Breast Cancer Cell Epithelial-mesenchymal transition and Cancer Stem Cell formation.
    Liu Q; Hodge J; Wang J; Wang Y; Wang L; Singh U; Li Y; Yao Y; Wang D; Ai W; Nagarkatti P; Chen H; Xu P; Murphy EA; Fan D
    Theranostics; 2020; 10(18):8365-8381. PubMed ID: 32724475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of 3D heterocellular spheroids of pancreatic ductal adenocarcinoma for the study of cell interactions in the tumor immune microenvironment.
    Giustarini G; Teng G; Pavesi A; Adriani G
    Front Oncol; 2023; 13():1156769. PubMed ID: 37519820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor-associated macrophages exhibit pro- and anti-inflammatory properties by which they impact on pancreatic tumorigenesis.
    Helm O; Held-Feindt J; Grage-Griebenow E; Reiling N; Ungefroren H; Vogel I; Krüger U; Becker T; Ebsen M; Röcken C; Kabelitz D; Schäfer H; Sebens S
    Int J Cancer; 2014 Aug; 135(4):843-61. PubMed ID: 24458546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 3D-3-culture: A tool to unveil macrophage plasticity in the tumour microenvironment.
    Rebelo SP; Pinto C; Martins TR; Harrer N; Estrada MF; Loza-Alvarez P; Cabeçadas J; Alves PM; Gualda EJ; Sommergruber W; Brito C
    Biomaterials; 2018 May; 163():185-197. PubMed ID: 29477032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual prognostic significance of tumour-associated macrophages in human pancreatic adenocarcinoma treated or untreated with chemotherapy.
    Di Caro G; Cortese N; Castino GF; Grizzi F; Gavazzi F; Ridolfi C; Capretti G; Mineri R; Todoric J; Zerbi A; Allavena P; Mantovani A; Marchesi F
    Gut; 2016 Oct; 65(10):1710-20. PubMed ID: 26156960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiplex quantitative analysis of stroma-mediated cancer cell invasion, matrix remodeling, and drug response in a 3D co-culture model of pancreatic tumor spheroids and stellate cells.
    Hwang HJ; Oh MS; Lee DW; Kuh HJ
    J Exp Clin Cancer Res; 2019 Jun; 38(1):258. PubMed ID: 31200779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.